InvestorsHub Logo
Followers 272
Posts 21702
Boards Moderated 1
Alias Born 10/01/2004

Re: texasholdem post# 20465

Tuesday, 12/12/2017 8:45:55 PM

Tuesday, December 12, 2017 8:45:55 PM

Post# of 37496
Hit the nail on the head there REVENUES $OMHE is building a self sustainable ship ULTRA RARE in OCT land AND also a key to success in biotech which can prove to be timely and costly specifically FDA trial process with $OMHE already producing revenue and planning on a strategic go 2 MARKET STRATEGY with inital deployment Over the Counter it sets us up perfectly for success for we will have plenty of money to fund Fast Track trials to obtain Orphan Drug designation and command a billion dollar plus market cap

Dear $OMHE Shareholders,
As we move into the second quarter (our financial year ends April 30th), I can honestly say that I have never been more optimistic about our opportunities for success. Omni Health’s annual revenues have grown to more than $4.6mln